Physician profile
Vance L Smith
NPI 1942414511
$9,797.16
in general payments reported to CMS, 2019-2025
12 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,120 · 2020: $5,334 · 2021: $277 · 2022: $195 · 2023: $665 · 2024: $1,763 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,768 · Travel and Lodging: $1,094 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,768.01 |
| Travel and Lodging | $1,094.22 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,284.30 | 2020 | |
| Intuitive Surgical, INC. | $2,124.90 | 2021-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $562.75 | 2023-2025 | Signia, Rapidvac, Nellcor |
| Medline Industries LP | $489.32 | 2019-2021 | |
| Covidien LP | $405.29 | 2019 | |
| Acell, INC. | $180.52 | 2019 | |
| Ethicon US, LLC | $147.54 | 2020-2023 | Echelon Endopath, Enseal, Harmonic |
| Integra Lifesciences Corporation | $143.48 | 2021 | |
| Conmed Corporation | $141.95 | 2024 | |
| W. L. Gore & Associates, INC. | $140.92 | 2021-2022 | |
| Octapharma USA, INC. | $93.76 | 2025 | Fibryga |
| Kci USA, INC. | $82.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vance Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.